Outcomes of immunosuppressive therapy discontinuation in patients with myelin oligodendrocyte glycoprotein antibody-associated disease. Kang YR, Ju H, Kim KH, Choo SH, et al. Mult Scler 2025;31:1102-1109.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kang YR, Ju H, Kim KH, Choo SH, et al. Outcomes of immunosuppressive therapy discontinuation in patients with myelin oligodendrocyte glycoprotein antibody-associated disease. Mult Scler 2025;31:1102-1109.
PMID: 40296497